Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Sees Significant Increase in Short Interest
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 2,580,000 shares, a growth of 20.6% from the April 30th total of 2,140,000 shares. Currently, 13.2% of the shares of the stock are short sold. Based on an average […]
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 2,580,000 shares, a growth of 20.6% from the April 30th total of 2,140,000 shares. Currently, 13.2% of the shares of the stock are short sold. Based on an average […]
